Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00GHG
|
|||
| Former ID |
DNCL003297
|
|||
| Drug Name |
VAX-102
|
|||
| Indication | Influenza A virus infection [ICD-11: 1E30] | Phase 2 | [1] | |
| Company |
VaxInnate
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00921947) Comparative Safety and Immunogenicity of 1.0 Intramuscular (i.m.) and 2.0 Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.